Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00762151 · ClinicalTrials.gov registry record · Phase 1
A Study to Investigate the Anti-Plaque Effect of AN0128 Toothpaste
A Phase 1 study of Dental Plaque, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT00762151: Completed Phase 1 study of Dental Plaque, sponsored by Pfizer.
NCT00762151 is a Phase 1 study of Dental Plaque that has completed, run by Pfizer. The registered enrollment target is 18 participants, below the 623-participant average among 10 other Dental Plaque trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00762151, a Phase 1 study of Dental Plaque, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study was to evaluate the anti-plaque efficacy of the Anacor prototype dentrifice as compared to commercial control products following a single use of the dentrifice.
Conditions Studied
Interventions
- OTHER Negative Control (Regular Toothpaste)
- OTHER Positive Control (anti-plaque/anti-bacterial toothpaste)
- DRUG Prototype (AN0128 Toothpaste)
Study Locations (1)
New Jersey
- Concordia Research Laboratories - Cedar Knolls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2007-11 |
| Est. Completion | 2008-01 |
| Phase | Phase 1 |
What the finished NCT00762151 record still lists
NCT00762151 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 623-participant average among 10 other Dental Plaque trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Dental Plaque appearing as the primary indexed condition, and to 3 interventions - of which Negative Control (Regular Toothpaste) is the first listed.
NCT00762151 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT00762151 about?
NCT00762151 is a clinical study titled "A Study to Investigate the Anti-Plaque Effect of AN0128 Toothpaste". The objective of this study was to evaluate the anti-plaque efficacy of the Anacor prototype dentrifice as compared to commercial control products following a single use of the dentrifice.
What is the current status of trial NCT00762151?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2007-11. Estimated completion is 2008-01.
What conditions does trial NCT00762151 study?
This clinical trial studies the following conditions: Dental Plaque.
What interventions are being tested in trial NCT00762151?
The interventions under investigation include: Negative Control (Regular Toothpaste) (OTHER), Positive Control (anti-plaque/anti-bacterial toothpaste) (OTHER), Prototype (AN0128 Toothpaste) (DRUG).
Who is sponsoring clinical trial NCT00762151?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00762151 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dental Plaque
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00762151's enrollment target sits among peer trials
18 10th of 10 higher than 1 of 10 other Dental Plaque trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dental Plaque trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Clinical Study to Evaluate the Effectiveness of an Experimental Toothpaste in Improving Gum Health and Reducing Plaque Accumulation
RECRUITING · NA
-
A Clinical Study to Evaluate the Efficacy of a Cetylpyridinium Chloride Mouthwash in Improving Gingival Health and Reducing Plaque Accumulation
COMPLETED · NA
-
Evaluating the Effect of Tooth Cleaning Devices on Oral Health
COMPLETED · NA
-
Meta-analysis of Stannous Fluoride and the Effects on Dental Plaque
COMPLETED
-
A Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste With a Cetylpyridinium Chloride Mouthwash in Improving Gingival Health and Reducing Plaque Accumulation
COMPLETED · NA
-
A Meta-analysis Comparing Toothbrushes on Plaque Removal and Gingival Health
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia